You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 13, 2025

Drug Price Trends for NDC 69238-1992


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 69238-1992

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
DIGOXIN 0.25MG TAB AvKare, LLC 69238-1992-01 100 15.89 0.15890 2023-06-15 - 2028-06-14 FSS
DIGOXIN 0.25MG TAB AvKare, LLC 69238-1992-07 1000 158.83 0.15883 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

69238-1992 Market Analysis and Financial Projection

Market Analysis and Price Projections for Drug NDC: 69238-1992

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies drug products, including prescription drugs, over-the-counter (OTC) drugs, and insulin products. This code is assigned by the FDA and includes the labeler code, product code, and package code[1][5].

Identifying the Drug

The NDC 69238-1992 can be broken down as follows:

  • Labeler Code: The first segment identifies the labeler, which could be the manufacturer, repackager, or relabeler.
  • Product Code: The second segment identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment identifies the package size and type.

To proceed with the analysis, one would need to look up the specific drug associated with this NDC in the FDA's NDC Directory.

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is undergoing significant changes, which can impact the pricing and market dynamics of drugs.

Continued Dominance of Small Molecule Drugs

Small molecule drugs continue to dominate the market, and their manufacturing and development are often outsourced to Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) to reduce costs and improve efficiency[3].

Growing Demand for Personalized Medicine

The increasing use of AI and advanced data analysis is driving the demand for personalized medicine. This trend could influence the pricing and market demand for specific drugs, especially those that can be tailored to individual patient needs[3].

Increasing Focus on Emerging Markets

Emerging markets are becoming key drivers of growth in the pharmaceutical industry due to large populations, rising disposable incomes, and increasing healthcare demand. This could affect the global pricing strategy for drugs[3].

Price Increases and Trends

Prescription drug prices have been a subject of significant concern due to their impact on affordability and healthcare costs.

Seasonal Price Increases

Most prescription drug price increases occur in January and July each year. In January 2022, the average price increase was nearly $150 per drug (10% increase), and in July 2022, it was $250 (7.8% increase)[2].

Significant Price Changes

Drugs with significant price changes (greater than $20 per package or a 10% change within a 12-month period) are particularly noteworthy. These changes can be substantial, with some drugs increasing their list prices by more than $20,000 or by more than 500%[2].

Impact of Patent Expiration

The expiration of patents can significantly affect drug prices. When a drug goes off patent, generic versions can enter the market, leading to a reduction in prices. For example, drugs like Januvia and Spiriva Respimat are projected to go off patent in the near future, which could lead to price reductions as generic alternatives become available[4].

Cost Savings Analysis

Importation programs and generic drug availability can also influence cost savings. For instance, the Colorado Section 804 Importation Program analysis suggests that importing Canadian prescription drugs could lead to significant cost savings due to lower prices in Canada compared to the U.S.[4].

Projecting Prices for NDC 69238-1992

To project prices for the specific drug identified by NDC 69238-1992, several factors need to be considered:

Current Market Price

Look up the current market price of the drug in the NDC Directory and other market databases.

Historical Price Trends

Analyze historical price trends for this drug, particularly focusing on any seasonal increases or significant price changes.

Patent Status

Check if the drug is nearing patent expiration, which could lead to generic competition and subsequent price reductions.

Market Demand and Competition

Assess the market demand and competition for this drug. If it is part of a growing segment like personalized medicine or has significant demand in emerging markets, this could influence pricing.

Regulatory and Policy Changes

Consider any regulatory or policy changes that might affect drug pricing, such as importation programs or new FDA regulations.

Example Projection

Assuming the drug associated with NDC 69238-1992 is a prescription drug with a current market price of $100 per unit:

  • Historical Trend: If the drug has historically seen a 10% increase in January and a 7.8% increase in July, similar increases could be projected for the upcoming year.
  • Patent Status: If the drug is not nearing patent expiration, the price might remain relatively stable unless there are significant market or regulatory changes.
  • Market Demand: If the drug is in high demand, especially in emerging markets or due to trends like personalized medicine, the price might see an upward trend.

Key Takeaways

  • NDC Understanding: The NDC is crucial for identifying and tracking drug products.
  • Market Trends: Small molecule drugs, personalized medicine, and emerging markets are key trends influencing the pharmaceutical industry.
  • Price Increases: Seasonal price increases, especially in January and July, are common.
  • Patent Expiration: Patent expiration can lead to significant price reductions.
  • Regulatory Changes: Importation programs and regulatory changes can impact drug prices.

FAQs

Q: What is the National Drug Code (NDC)? A: The NDC is a unique, three-segment number that identifies drug products, including prescription drugs, OTC drugs, and insulin products.

Q: How often are price increases for prescription drugs? A: Most price increases occur in January and July each year.

Q: What happens to drug prices when a patent expires? A: When a drug goes off patent, generic versions can enter the market, leading to a reduction in prices.

Q: How do emerging markets affect the pharmaceutical industry? A: Emerging markets drive growth due to large populations, rising disposable incomes, and increasing healthcare demand.

Q: What role does AI play in the pharmaceutical industry? A: AI is driving advancements in drug discovery, personalized medicine, and process optimization.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Price Increases for Prescription Drugs, 2016-2022 - ASPE
  3. Top 12 Pharmaceutical Industry Trends in 2024 - Global Pharma Tek
  4. Colorado Section 804 Importation Program Cost Analysis - HCPF
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.